VDR and vitamin D deficiency: The high incidence of vitamin D deficiency in allogeneic HSCT patients, alongside the current controversy (9, 11, 84, 114, 115, 132, 141), emphasizes the need for further studies on the impact of vitamin D deficiency and VDR gene polymorphisms on clinical outcomes to define its role as a biomarker in this setting.